Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery



Status:Recruiting
Healthy:No
Age Range:30 - Any
Updated:3/1/2019
Start Date:November 8, 2018
End Date:August 8, 2024
Contact:Rafat Abonour, MD
Email:rabonour@iu.edu
Phone:3179486871

Use our guide to learn which trials are right for you!

Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery

Screening study to determine incidence of MGUS in this patient population

This study is designed to observe the incidence of monoclonal gammopathy of undetermined
significance (MGUS) among obese patients planning to have weight reduction surgery or
planning to enter into a physician monitored weight loss program and to follow the regression
or progression of MGUS following surgery or the initiation of the weight loss program.

Inclusion Criteria:

1. Male or female patients 30 years or older planning to undergo weight reduction surgery
or planning to enter into a physician monitored weight loss program

2. Patients must be obese, defined as a BMI ≥ 30 as calculated by the formula:

weight in pounds / height squared x 703 = BMI

3. Subject consent and authorization for the release of health information must be
obtained according to local institutional guidelines.

4. To remain in the study for the follow-up phase, the baseline screening test must
indicate that a patient has MGUS.

Exclusion Criteria:

1. No history of any malignancy except: adequately treated non-melanoma skin cancer,
curatively treated in-situ cancer of the cervix, or other solid tumors curatively
treated with no evidence of disease for ≥ 5 years.

2. No concurrent or planned participation in randomized trials of weight loss.

3. A patient will be excluded from the follow-up phase if the baseline screening test
indicates they do not have MGUS
We found this trial at
1
site
Indianapolis, Indiana 46202
Phone: 317-948-6871
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials